生育治疗后输卵管卵巢脓肿患者复杂的临床病程与不良生殖结局
该平行病例系列比较了37例生育治疗(体外受精和宫腔内人工授精)后诊断输卵管卵巢脓肿(TOA)的女性与同期313例非生育治疗相关TOA女性。生育治疗后TOA患者入院时炎症标志物更高、手术干预率更高、临床病程更复杂、住院时间更长,每周期临床妊娠率9%,仅记录1例活产。作者认为生育治疗后TOA对临床病程和手术结局有实质性影响,建议对感染风险患者取卵前预防性使用抗生素并推迟胚胎移植。
要点
- 生育治疗后TOA患者入院时平均白细胞计数16.1×1000/mm3、平均C反应蛋白149 mg/L,均高于非生育治疗组。
- 生育治疗后TOA患者腹腔镜转开腹率14.2%、围手术期并发症率25.0%,均高于非生育治疗组。
- 生育治疗后TOA患者每周期临床妊娠率9%,仅记录1例活产。
核心结论
- 作者认为生育治疗后TOA对临床病程和手术结局有实质性影响,建议对感染风险患者取卵前预防性使用抗生素并推迟胚胎移植。
研究设计与样本
- 平行病例系列,连续10年,加拿大工作组分类II-2。
- 地点为Tel Aviv Sourasky Medical Center,一所大学附属三级医院。
- 纳入37例生育治疗(体外受精和宫腔内人工授精)后诊断TOA的女性,与同期313例非生育治疗相关TOA女性比较。
- 干预为病历检索、图表回顾和电话调查,用以评估临床病程及手术和生殖结局。
主要发现
- 生育治疗后TOA组入院时平均白细胞计数16.1×1000/mm3(标准差±4.3)vs 非生育治疗组13.8×1000/mm3(标准差±6.3),p=.001。
- 生育治疗后TOA组平均C反应蛋白149 mg/L(标准差±78.3)vs 非生育治疗组78.2 mg/L(标准差±68.5),p=.001。
- 生育治疗后TOA组入院至手术时间2.1天 vs 非生育治疗组3.2天,p=.01。
- 生育治疗后TOA组腹腔镜转开腹率14.2% vs 非生育治疗组3.2%,p=.005;围手术期并发症率25.0% vs 3.8%,p=.0001;住院时间7.2天 vs 4.8天,p=.01。
- 生育治疗后TOA组每周期临床妊娠率9%,记录1例活产。
关键数值与推荐
- 生育治疗后TOA组抗生素失败率更高(原文未给出具体数值和P值)。
临床怎么用
- 作者建议对感染风险患者取卵前预防性使用抗生素并推迟胚胎移植。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To assess the clinical course and surgical and fertility outcomes of patients diagnosed with tubo-ovarian abscess (TOA) after fertility treatment. DESIGN: Parallel case series over 10 consecutive years (Canadian Task Force classification II-2). SETTING: Tel Aviv Sourasky Medical Center, a tertiary university-affiliated hospital. PATIENTS: Thirty-seven women who were diagnosed with TOA after fertility treatments (in vitro fertilization and intrauterine insemination) were compared with 313 women who were diagnosed with TOA not associated with fertility treatments during the same time period. INTERVENTION: Medical records search, chart review, and phone survey were used to assess clinical course and surgical and reproductive outcomes. MEASUREMENTS AND MAIN RESULTS: Women with TOA after fertility treatments had significantly higher inflammatory markers upon admission compared with the nonfertility treatment group (mean white blood cell count, 16.1 × 1000/mm3 [standard deviation [SD], ±4.3] vs 13.8 × 1000/mm3 [SD, ±6.3], p = .001, respectively; and mean C-reactive protein, 149 mg/L [SD, ±78.3] vs 78.2 mg/L [SD, ±68.5], p = .001, respectively). In addition, TOA after fertility treatments was associated with a significantly higher surgical intervention rate and a more complicated clinical course, as evidenced by a shorter time interval from admission to surgery (2.1 days vs 3.2 days, p = .01), higher rates of antibiotic failure, higher conversion rate from laparoscopy to laparotomy (14.2% vs 3.2%, p = .005), increased perioperative complications rate (25.0% vs 3.8%, p = .0001), and a longer hospitalization stay (7.2 days vs 4.8 days, p = .01). Clinical pregnancy rate per cycle in women with TOA after fertility treatments was 9%, and 1 case of live birth was recorded. CONCLUSIONS: Our data indicate that TOA after fertility treatment has a substantial effect on the clinical course and surgical outcome. Prophylactic antibiotic treatment before ovum retrieval and deferral of embryo transfer should be considered in patients at risk of infection.
引用
- Fouks Y, Cohen Y, Tulandi T, et al. Complicated Clinical Course and Poor Reproductive Outcomes of Women with Tubo-Ovarian Abscess after Fertility Treatments. J Minim Invasive Gynecol. 2018. PMID: 29890350. doi:10.1016/j.jmig.2018.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。